> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# IC-Green Not Withdrawn Due to Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/ic-green-not-withdrawn-due-to-safety-efficacy-fda/
- Published: 2018-12-13T12:00:00.000Z
- Updated: 2026-09-15T00:50:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143036

*Federal Register* notice: FDA has determined that Akorn’s IC–Green (indocyanine green for injection), 10 milligrams (mg)/vial, 40 mg/vial, and 50 mg/vial, was not withdrawn from sale for reasons of safety or effectiveness. The determination will allow FDA to approve ANDAs for indocyanine green for injection, 10 mg/vial, 40 mg/vial, and 50 mg/vial if all other legal and regulatory requirements are met. The determination was made after Foley & Lardner submitted a citizen petition 5/3\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-12-13/pdf/2018-26975.pdf?ref=fdaweb.com).